RoB 2: A revised tool for assessing risk of bias in randomised trials

Jonathan A.C. Sterne, Jelena Savović, Matthew J. Page, Roy G. Elbers, Natalie S. Blencowe, Isabelle Boutron, Christopher J. Cates, Hung Yuan Cheng, Mark S. Corbett, Sandra M. Eldridge, Jonathan R. Emberson, Miguel A. Hernán, Sally Hopewell, Asbjørn Hróbjartsson, Daniela R. Junqueira, Peter Jüni, Jamie J. Kirkham, Toby Lasserson, Tianjing Li, Alexandra McAleenanBarnaby C. Reeves, Sasha Shepperd, Ian Shrier, Lesley A. Stewart, Kate Tilling, Ian R. White, Penny F. Whiting, Julian P.T. Higgins

Research output: Contribution to journalArticle

Original languageEnglish (US)
Article numberl4898
JournalThe BMJ
Volume366
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H. Y., Corbett, M. S., Eldridge, S. M., Emberson, J. R., Hernán, M. A., Hopewell, S., Hróbjartsson, A., Junqueira, D. R., Jüni, P., Kirkham, J. J., Lasserson, T., Li, T., ... Higgins, J. P. T. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. The BMJ, 366, [l4898]. https://doi.org/10.1136/bmj.l4898